The impact of the Coronavirus on the supply chain
Our expert's opinion:
"Supply Chain is the engine of every production company in the world. When one chain isn't working correctly, no matter how small it seems, the whole chain threatens to collapse and it won't take a long time before the whole company will feel the effect of this issue. If the malfunction of one chain goes on for a long time and no alternative can be proposed, this can have a huge impact on the company, their clients and the market.
Since December 2019 there is something new threatening our Supply Chains: COVID-19 Coronavirus. Although it's not widely spread in Belgium yet, it's already having an impact on our business and worldwide economy. This is because China is a really important supplier of raw materials for Belgian factories active in textile, chemicals and machinery. Next to a supplier, China is also an important market for export.
At this point, everyone is trying to be prepared and looking for alternatives in Europe but besides the fact that some raw materials aren't available in Europe, we also have to acknowledge the fact that the virus is also spreading in Europe and that the threat isn't over yet.
What will the impact be of the Coronavirus on the Belgian companies with an international supply chain and can we protect or prepare ourselves to prevent losses because of this source in the future?"
- Yenthe Huysmans, Associate Consultant
How fast can a virus destroy a supply chain?
The global supply chain, already under pressure from U.S. President Donald Trump’s trade war, now faces further strain from the COVID-19 coronavirus. And while cross-national supply chains are more robust than they may appear, if they fail they will do so suddenly and without much warning.
Supply chains are not indestructible
Consider the supply chain of the Apple iPhone, which stretches across dozens of companies and several continents. Such complex cross-national supply chains generate relatively high profits, giving them a kind of immunity to small disruptions. If there is an unexpected tax, tariff or exchange movement, the supply chain can generally swallow the costs and move on. Profits will be lower within the supply chain, but production will continue, as it is too lucrative to simply shut everything down.
Do not be deceived, however. Supply chains are not indestructible. If the new costs or risks are high enough, the entire structure will be dismantled. By their nature, supply chains do not fall apart slowly, because each part of the chain relies upon other parts to add its value. It does not help much to have the circuit components of the iPhone lined up, for instance, if you cannot also produce the glass screens.
In this way, these supply chains are less robust under extreme conditions.
Global supply chains have yet to come apart mostly because trade and prosperity generally have been rising. But now, for the first time since World War II, the global economy faces the possibility of a true decoupling of many trade connections.
It is not sufficiently well understood how rapid that process could be. A complex international supply chain is fragile precisely for the same reasons it is valuable — namely, it is hard to construct and maintain because it involves so many interdependencies.
The nature of the cross-national supply chain makes it especially vulnerable to shocks coming from the coronavirus. These supply chains do not adapt so well to complete cutoffs in materials or labor, as may happen if Chinese coronavirus casualties continue and workplaces find it hard to operate effectively.
Chinese medicine components
Imagine that closed Chinese factories cannot produce the components of many American medicines. It is not a question of the supply chain simply losing some profits; rather, some critical pieces of the production process are missing. The medicines won’t work without these inputs. The U.S. medical establishment might try to source those components elsewhere, but it isn’t easy for other suppliers to produce enough of them at sufficient scale and quality.
U.S. medical producers might try to bid more for the Chinese medicine components, but if the workers are prohibited from even showing up at the factory, no feasible market clearing price can make this arrangement work. Production just won’t be possible. Fashionable practices of near-zero inventories can make these shortages appear all the more rapidly. About 80 percent of the active pharmaceutical ingredients in U.S. medicines rely on Chinese or Indian components, so this does represent a very real public health risk for the United States, even if the coronavirus itself does not.
India, of course, also may prove vulnerable to the coronavirus, because it has high population density and relatively weak public health institutions. China is the world’s No. 2 economy, but it is not the only vulnerable part of the global supply chain in this regard.
In contrast, the older, less global, supply chains were less vulnerable to these kinds of risks. If the production of medical components were at risk within the borders of the U.S., American officials could take regulatory or private-company actions to help maintain supply. U.S. officials don’t have the same leverage over conditions in China or India.
So far the best bet is that current international supply chains will hold, for the most part, and deliver the goods. But the chance that they will not is rising sharply, as both the trade war and the coronavirus strengthen the hand of those who advocate for more dismantling of international trade networks. And if that dismantling does occur, it is likely to snap into place suddenly — with neither market prices nor advance warning offering much protection. The more people start to believe that long, complex cross-national supply chains are risky, the more fragile they will turn out to be.